Heritage Cannabis Teams with Patient Choice to Offer Medical Cannabis to Patients Across Canada

Purefarma and Pura Vida now available through new Health Canada licensed platform TORONTO–(BUSINESS WIRE)–Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) (“Heritage”or the “Company”), today announced that its products, including the Purefarma and Pura Vida brands, are available for purchase on the Patient Choice online platform. Patient Choice is a Health Canada licensed virtual portal that gives medical cannabisContinue reading “Heritage Cannabis Teams with Patient Choice to Offer Medical Cannabis to Patients Across Canada”

Curaleaf Continues Western Expansion of Select Brand Products

— Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading vertically integrated cannabis operator in the United States, today launched its Select Nano Gummies in California and its line of Select Elite Live cartridges in Nevada. Select, America’s #1 Cannabis Oil Brand, is a West Coast lifestyle brand that was acquired by Curaleaf in February 2020. Utilizing nano-emulsionContinue reading “Curaleaf Continues Western Expansion of Select Brand Products”

MediPharm Labs Australia Expands Revenue Opportunity On Expanded GMP Licence

— MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced that its Australian operation – MediPharm Labs Australia Pty. Ltd. (“MediPharm Labs Australia”) – has received an important enabling amendment to its Good Manufacturing Practice (“GMP”) Certification and LicenceContinue reading “MediPharm Labs Australia Expands Revenue Opportunity On Expanded GMP Licence”

Canada House Wellness Group Announces $6.5 Million Strategic Investment From Archerwill Investments

-Canada House Wellness Group Inc. (CSE: CHV) (“Canada House“, or the “Company“), is pleased to announce that it has entered into a subscription agreement (the “Subscription Agreement“) with Archerwill Investments Inc. (“Archerwill“) for a strategic investment in Canada House (the “Transaction“). Transaction Highlights Archerwill will invest $6,500,000 in the form of a secured convertible debenture (the “Debenture“) to obtain aContinue reading “Canada House Wellness Group Announces $6.5 Million Strategic Investment From Archerwill Investments”

The Valens Company Announces Participation in First-of-its-Kind Real-World Evidence Study on Medical Cannabis Led by the University Health Network in Partnership with Shoppers Drug Mart

 –The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the “Company” or “The Valens Company“), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, today announced its participation in a Medical Cannabis Real-World Evidence Study (the “MC-RWE Study“) led by Dr. Hance Clarke of the University Health Network (UHN) in Toronto, Canada. The study will explore theContinue reading “The Valens Company Announces Participation in First-of-its-Kind Real-World Evidence Study on Medical Cannabis Led by the University Health Network in Partnership with Shoppers Drug Mart”

Cresco Labs Closes Sale-and-Leaseback for Massachusetts Facility and Expands Real Estate Partnership with Innovative Industrial Properties

—Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), one of the largest vertically integrated multistate cannabis operators in the United States, today announced that it has closed the agreement to its sell and lease back its Fall River, MA property to Innovative Industrial Properties, Inc. (“IIP”). Consideration for the sale was approximately $29 million, which includesContinue reading “Cresco Labs Closes Sale-and-Leaseback for Massachusetts Facility and Expands Real Estate Partnership with Innovative Industrial Properties”